CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 vs Zio ECG Utilization Software (ZEUS) System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

These tools are adjacent in the cardiology AI space, both addressing cardiac arrhythmias but with distinct applications. Tool B focuses on remote, continuous ECG monitoring and AI-powered diagnosis, providing comprehensive reports for physicians. In contrast, Tool A is an interventional system designed for real-time 3D cardiac mapping and navigation during electrophysiology procedures in a lab setting.

Choose CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 if…

Choose CARTO™ 3 EP Navigation System Software V8.0 if your practice requires an advanced, real-time 3D cardiac mapping and navigation solution for invasive electrophysiology procedures. This system is ideal for electrophysiologists performing complex ablations for conditions like AFib and VT, needing precise catheter visualization and detailed anatomical mapping to guide treatment.

View CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 →

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose Zio ECG Utilization Software (ZEUS) System if you need a comprehensive, AI-powered cloud-based platform for long-term, non-invasive cardiac arrhythmia detection and management. This tool is best suited for physicians seeking to analyze continuous ECG data from wearable monitors to diagnose intermittent arrhythmias and monitor patient heart rhythms remotely over extended periods.

View Zio ECG Utilization Software (ZEUS) System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 Zio ECG Utilization Software (ZEUS) System
Pricing Contact for pricing Unknown
Deployment On-premise (EP lab system) with optional cloud-based data storage (CARTONET™) Cloud-based.
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio ECG Utilization Software (ZEUS) System

While both tools prioritize usability within their specific contexts, Tool B offers broader accessibility and ease of use through its cloud-based platform, web portal, and mobile application, which streamlines remote monitoring workflows for a wider range of healthcare professionals and enhances patient engagement. Tool A is highly specialized for an EP lab, focusing on optimizing complex interventional procedures with features like streamlined workflow and automatic catheter recognition.

Clinical Value

Tie

Both tools demonstrate significant clinical value, are FDA-cleared, and leverage AI to improve cardiac care. Tool A provides real-time, AI-powered 3D mapping and navigation for complex interventional procedures, directly impacting treatment efficacy and potentially reducing fluoroscopy use. Tool B offers superior long-term diagnostic monitoring with deep-learned algorithms, leading to earlier detection and improved management of arrhythmias, with studies showing higher diagnostic yield compared to traditional methods.

Pricing & Value

Tie

Both products explicitly state that pricing is not publicly available and requires direct consultation with sales representatives. Without any transparent pricing information or comparative cost-effectiveness studies readily accessible, it is impossible to determine which offers better pricing or overall value.

Enterprise Readiness

Zio ECG Utilization Software (ZEUS) System

Tool B demonstrates superior enterprise readiness due to its fully cloud-based deployment on AWS EC2, explicit HL7-based EHR integration, and highly scalable, geographically distributed architecture with redundant systems. While Tool A offers optional cloud storage and compliance for its associated platform, its primary on-premise deployment may present more specific IT integration challenges for large-scale enterprise adoption compared to Tool B's cloud-native approach.

Innovation

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

While both tools are highly innovative, Tool A's integration of AI and deep learning into real-time 3D cardiac mapping and navigation for interventional procedures, including automated anatomy creation and enhanced signal analysis, represents a more complex and cutting-edge application within a surgical context. Tool B's innovation lies in its scalable, AI-driven remote monitoring and wearable biosensors, which is significant but perhaps less complex in its real-time, procedural application.

Support & Docs

Tie

Both companies appear to offer comprehensive support and documentation. Tool A provides a 'Therapy Advancement Program' and 'Training Expertise Centers' for optimized workflows, along with on-screen troubleshooting. Tool B offers a web portal for managing clinical workflows and provides Instructions for Use in multiple languages, alongside customer care services. Neither explicitly stands out as definitively superior in this dimension based on the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 Zio ECG Utilization Software (ZEUS) System
Name CARTOu2122 3 EP Navigation System Software V8.0 (FG-5400-00 Zio ECG Utilization Software (ZEUS) System
Company Biosense Webster, Inc. iRhythm Technologies
Description The CARTOu2122 3 EP Navigation System Software V8.0 by Biosense Webster is an FDA-cleared, AI-powered 3D cardiac mapping and navigation system for electrophysiologists, enhancing diagnosis and treatment of heart rhythm disorders like AFib and VT. The Zio ECG Utilization Software (ZEUS) System by iRhythm Technologies is an AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
Key Features Advanced Catheter Location (ACL) technology for accurate catheter visualization, Fast Anatomical Mapping (FAM) for rapid, high-resolution 3D cardiac maps, Connection of Choice for streamlined workflow and automatic catheter recognition, CARTO ELEVATEu2122 Module with machine learning for enhanced signal analysis and substrate characterization, CARTOSOUNDu2122 FAM Module utilizing AI/deep-learning for automated 3D left atrial anatomy creation, Enhanced CONFIDENSEu2122 Module for optimized map creation and data validation, LAT Velocity Vectors for visualizing activation wave velocity over substrate maps, Stability+ algorithm for continuous analysis of ablation catheter movement AI algorithm for arrhythmia detection and classification, Continuous ECG data analysis (up to 14 days), Cloud-based data analytics (AWS EC2 platform), Proprietary deep-learned algorithms for enhanced diagnostic accuracy, ZioSuite web portal and mobile application for healthcare professionals, Comprehensive end-of-wear reports for physician review, Integration with Zio wearable biosensors (Zio monitor, Zio Watch), HL7-based EHR integration
Categories Cardiology AI, Surgical AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 and Zio ECG Utilization Software (ZEUS) System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.